[PAR] [TLE] Galderma [SEP] Galderma S.A. is a pharmaceutical subsidiary specializing in the research, development and marketing of dermatological treatments and became a wholly owned subsidiary of Nestlé in 2014. [PAR] [TLE] Lymecycline [SEP] Lymecycline is a tetracycline broad-spectrum antibiotic marketed by the pharmaceutical company Galderma.  It is approximately 5,000 times more soluble than tetracycline base and is unique amongst tetracyclines in that it is absorbed by an active transport process across the intestinal wall, making use of the same fast and efficient mechanism by which carbohydrates are absorbed.
[PAR] [TLE] Galderma [ SEP ] Galderma S.A. is a pharmaceutical subsidiary specializing in the research , development and marketing of dermatological treatments and became a wholly owned subsidiary of Nestlé in 2014 . [PAR] [TLE] Lymecycline [ SEP ] Lymecycline is a tetracycline broad - spectrum antibiotic marketed by the pharmaceutical company Galderma . It is approximately 5,000 times more soluble than tetracycline base and is unique amongst tetracyclines in that it is absorbed by an active transport process across the intestinal wall , making use of the same fast and efficient mechanism by which carbohydrates are absorbed .
Lymecycline is marketed by the company that became a subsidiary of what multinational in 2014?
Lymecycline is marketed by the company that became a subsidiary of what multinational in 2014 ?
Nestlé
Nestlé